Literature DB >> 22284732

Structural neuroimaging in aging and Alzheimer's disease.

Meike W Vernooij1, Marion Smits.   

Abstract

The role of structural neuroimaging in the diagnosis of Alzheimer's disease (AD) is becoming increasingly important. As a consequence, a basic understanding of what are normal brain changes in aging is key to be able to recognize what is abnormal. The first part of this article discusses normal versus pathologic brain aging, focusing on qualitative and quantitative magnetic resonance (MR) imaging markers. In the second part, the role of MR imaging in the (differential) diagnosis of AD is reviewed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22284732     DOI： 10.1016/j.nic.2011.11.007

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN： 1052-5149            Impact factor:   2.264


  12 in total

1.  Magnetic resonance imaging study of a simian/human immunodeficiency virus-infected Chinese rhesus macaque with HIV-associated dementia.

Authors:  Jie-Liang Li; Ke Zhuang; Guang-Yao Wu; Wen-Zhe Ho
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03       Impact factor: 2.205

2.  The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.

Authors:  Leah H Rubin; Erin E Sundermann; David J Moore
Journal:  J Neurovirol       Date:  2019-01-22       Impact factor: 2.643

Review 3.  Recent Advances in Leukoaraiosis: White Matter Structural Integrity and Functional Outcomes after Acute Ischemic Stroke.

Authors:  Mark R Etherton; Ona Wu; Natalia S Rost
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

Review 4.  A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Biol Psychiatry       Date:  2013-11-28       Impact factor: 13.382

5.  Hyperplanar Morphological Clustering of a Hippocampus by Using Volumetric Computerized Tomography in Early Alzheimer's Disease.

Authors:  Sarawut Suksuphew; Paramate Horkaew
Journal:  Brain Sci       Date:  2017-11-21

6.  Automatic normative quantification of brain tissue volume to support the diagnosis of dementia: A clinical evaluation of diagnostic accuracy.

Authors:  Meike W Vernooij; Bas Jasperse; Rebecca Steketee; Marcel Koek; Henri Vrooman; M Arfan Ikram; Janne Papma; Aad van der Lugt; Marion Smits; Wiro J Niessen
Journal:  Neuroimage Clin       Date:  2018-08-09       Impact factor: 4.881

7.  Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group.

Authors:  M W Vernooij; F B Pizzini; R Schmidt; M Smits; T A Yousry; N Bargallo; G B Frisoni; S Haller; F Barkhof
Journal:  Neuroradiology       Date:  2019-03-09       Impact factor: 2.804

8.  Clinically accessible neuroimaging predictors of post-stroke neurocognitive disorder: a prospective observational study.

Authors:  Till Schellhorn; Eva Birgitte Aamodt; Stian Lydersen; Stina Aam; Torgeir Bruun Wyller; Ingvild Saltvedt; Mona Kristiansen Beyer
Journal:  BMC Neurol       Date:  2021-02-25       Impact factor: 2.474

9.  Pre-stroke cognitive impairment is associated with vascular imaging pathology: a prospective observational study.

Authors:  Till Schellhorn; Manuela Zucknick; Torunn Askim; Ragnhild Munthe-Kaas; Hege Ihle-Hansen; Yngve M Seljeseth; Anne-Brita Knapskog; Halvor Næss; Hanne Ellekjær; Pernille Thingstad; Torgeir Bruun Wyller; Ingvild Saltvedt; Mona K Beyer
Journal:  BMC Geriatr       Date:  2021-06-14       Impact factor: 3.921

Review 10.  Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review.

Authors:  Hugh G Pemberton; Lara A M Zaki; Olivia Goodkin; Ravi K Das; Rebecca M E Steketee; Frederik Barkhof; Meike W Vernooij
Journal:  Neuroradiology       Date:  2021-09-03       Impact factor: 2.804
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.